News
Prothena Corporation plc (NASDAQ:PRTA) is an Ireland-based late-stage clinical biotechnology company that identifies and ...
Featuring works from Chelsea Odufu, Laurena Finéus, Jarrett Key, and more, the show challenges how we encounter personal ...
Fonroche’s efficient, solar-powered lights will save the city approximately $3 million in annual energy costs Fonroche ...
They are back in the Stanley Cup Finals, but a new wave of fans are again enjoying one of hockey’s most beloved playoff traditions. Will we see the rats?
5h
Zacks Investment Research on MSNAbbVie's Venclexta Misses Goal in Myelodysplastic Syndromes StudyAbbVie ABBV announced that the phase III VERONA study failed to meet the primary endpoint of overall survival. The study ...
Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an ...
Explore more
Venclexta, when combined with azacitidine, elicited an overall survival benefit below 10% in patients with myelodysplastic ...
Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis and isolation, today ...
This is the Mediterranean diet and why doctors recommend it: Food list, healthy recipes and benefits
Fruits, vegetables, grains, protein... everything you need to know about the diet that’s hitting the headlines again.
It was a fairly solid showing for most of South Africa's franchises as three of them reached the URC knockouts, and kept ...
Other appointments to BIO's board for the 2025 through 2026 term include: Arcutis Bio's Frank Watanabe, named vice-chair; ...
The Hôtel de Rochechouart opens its doors to the public this Saturday, June 21, 2025, to mark the new Fête de la Musique, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results